Discovery & Innovation

Steve Blank wrote an excellent 3 part blog series last week. We covered Part 1 which described the challenges Life Science companies face in...

Interesting news for those thinking about personalized medicine and drug development: children born to mothers after bariatric gastrointestinal...

Life science companies are known to be one of the most expensive and difficult to start up. We look for an answer as to why in an excellent article...

Almost weekly in the news there is an article about a new scientific breakthrough and how animal models were instrumental in making this discovery...

An oncogene is a gene that can potentially cause cancer. RAS is a common class of oncogene and the focus of researchers worldwide, particularly at...

While the mouse may be king, it’s not the only show in town. Beyond the mouse, several other species are used as animal models of human disease...

As previously discussed, there is great value in using in vivo models such as genetically modified mice and xenograft models for oncology research...

Xenograft is animal tissue implanted into a different species and is often used for evaluating treatment for disease and organ failure. Currently...

Oncology research using genetically engineered mice (GEM) to express oncogenes and model cancers has grown exponentially in the past 30 years...

This is Part 3 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...